首页|期刊导航|实用临床医药杂志|抗帕颗粒联合益生菌对帕金森病模型小鼠血清短链脂肪酸的协同调节作用

抗帕颗粒联合益生菌对帕金森病模型小鼠血清短链脂肪酸的协同调节作用OA

Synegistic regulatory effect of Kangpa Granule combined with probiotics on serum short-chain fatty acids in a mouse model of Parkinson's disease

中文摘要英文摘要

目的 探讨中药复方抗帕颗粒与益生菌单用及联用对1-甲基-4-苯基-1,2,3,6-四氢吡啶(MPTP)诱导的帕金森病(PD)模型小鼠血清短链脂肪酸(SCFAs)代谢的影响.方法 将100只C57BL/6雄性小鼠随机分为正常对照组(A组)、PD模型组(B组)、PD益生菌干预组(C1组)、PD抗帕颗粒干预组(C2组)、PD益生菌与抗帕颗粒联合干预组(C3组).除A组外,其余各组腹腔注射MPTP40 mg/(kg·d)连续5 d以建立PD模型;造模后,各组接受相应灌胃干预12周.分别于造模后干预前及干预12周后采集各组小鼠血清,采用气相色谱-质谱联用(GC-MS)技术检测8种SCFAs(乙酸、丙酸、丁酸、异丁酸、戊酸、异戊酸、己酸、异己酸)水平,并进行主成分分析(PCA).结果 与A组相比,B组小鼠血清乙酸、丁酸、己酸水平在造模后干预前及干预12周后均降低,差异有统计学意义(P<0.01,Bonferroni校正后仍显著).干预12周后,C1组、C2组、C3组的血清乙酸、丁酸、己酸水平均较干预前升高,差异有统计学意义(P<0.05或P<0.01),大多恢复至接近A组水平.干预12周后,C3组血清丙酸、戊酸水平高于B组、A组、C1组及C2组,差异有统计学意义(P<0.01,Bonferroni校正后仍显著).各组不同时点血清异丁酸、异戊酸、异己酸水平比较,差异均无统计学意义(P>0.05).PCA结果显示,干预后C3组的整体SCFAs代谢谱与其他组别明显分离,形成了独特的代谢稳态.结论 MPTP诱导的PD小鼠存在以血清乙酸、丁酸、己酸水平降低为特征的SCFAs代谢紊乱.益生菌与抗帕颗粒单用均可有效部分纠正这一紊乱,而两者联用能协同提升丙酸与戊酸水平,有效重塑SCFAs代谢谱,为基于肠-脑轴的PD治疗策略提供了初步的实验依据.

Objective To investigate the effects of single use of Chinese herbal formula Kangpa Granule and probiotics,and their combination on serum short-chain fatty acid(SCFAs)metabolism in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine(MPTP)-induced mouse model of Parkinson's disease(PD).Methods A total of 100 male C57BL/6 mice were randomly divided into normal control group(group A),PD model group(group B),PD probiotic intervention group(group C1),PD Kangpa Granule intervention group(group C2),and PD probiotic and Kangpa Granule combined intervention group(group C3).Except for group A,all groups received intraperitoneal injection of MPTP 40 mg/(kg·d)for 5 consecutive days to establish the PD model.After modeling,each group received the corresponding intragastric intervention for 12 weeks.Serum samples were collected before the post-modeling intervention and after the 12-week intervention.Gas chromatography-mass spectrometry(GC-MS)was used to measure the levels of eight SCFAs(acetic acid,propionic acid,butyric acid,isobutyric acid,valeric acid,isovaleric acid,caproic acid,and isocaproic acid),and principal component analysis(PC A)was performed.Results Compared with group A,the serum levels of acetic acid,butyric acid,and caproic acid in group B were decreased both before the post-modeling intervention and after the 12-week intervention,and the differences were statistically significant(P<0.01,remaining significant difference after Bonferroni correction).After 12-week interven-tion,the serum levels of acetic acid,butyric acid,and caproic acid in groups C1,C2,and C3 were significantly higher than those before the intervention(P<0.05 or P<0.01),mostly approaching to those of group A.After 12-week intervention,the serum levels of propionic acid and valeric acid in group C3 were significantly higher than those in groups B,A,C1,and C2(P<0.01,remaining significant difference after Bonferroni correction).There were no statistically significant differences in the serum levels of isobutyric acid,isovaleric acid,and isocaproic acid among the groups at any time point(P>0.05).PCA results showed that the overall SCFA metabolic profile of group C3 was clearly separated from those of the other groups after the intervention,forming a distinct metabolic homeostasis.Conclusion MPTP-induced PD mice exhibit SCFA metabolic dysregulation character-ized by decreased serum levels of acetic acid,butyric acid,and caproic acid.Single use of probiot-ics and Kangpa Granule can partially correct this dysregulation,whereas their combined use syner-gistically elevates the levels of propionic acid and valeric acid,effectively remodels the SCFA meta-bolic profile,and provides a preliminary experimental basis for gut-brain axis-based therapeutic strategies for PD.

徐慧;刘慧琴;王思思;王永兵;赵晓晖

上海市浦东新区人民医院,神经内科,上海,201200上海市浦东新区人民医院,神经内科,上海,201200上海市浦东新区人民医院,神经内科,上海,201200上海市浦东新区人民医院,普外科,上海,201200上海市浦东新区人民医院,神经内科,上海,201200

医药卫生

帕金森病小鼠短链脂肪酸抗帕颗粒益生菌肠-脑轴气相色谱-质谱联用主成分分析

Parkinson's diseasemouseshort-chain fatty acidsKangpa Granuleprobioticsgut-brain axisgas chromatography-mass spectrometryprincipal component analysis

《实用临床医药杂志》 2026 (15)

22-27,33,7

上海市科学技术委员会自然科学基金资助项目(13ZR1437)上海市浦东新区卫生系统重点学科建设资助项目(PWZxk2022-23)

10.7619/jcmp.20262081

评论